EEOC Indicates Testing Employees for COVID-19 Does Not Violate ADA
2 min read
May 22, 2020
As businesses prepare to re-open, many employers will be concerned about the risk of workplace transmission of the COVID-19 disease. Testing employees before allowing them to enter the workplace is one preventative measure employers are considering. However, this measure has been clouded by uncertainty, because a test for COVID-19 could be considered a medical inquiry under the Americans with Disabilities Act (ADA), which is only permitted if the inquiry is job-related and consistent with business necessity.
In an effort to provide clarity, the Equal Employment Opportunity Commission (EEOC) has now issued guidance regarding employer testing of employees for COVID-19 before they enter the workplace. This guidance states that employers can require employees to undergo a COVID-19 test before entering the workplace without violating the ADA. The EEOC suggests that employers review the Federal Drug Administration's (FDA's) recommendations on testing.
Many laboratories are providing COVID-19 testing. However, it is critical that employers who opt to test employees for COVID-19 use a laboratory that is providing accurate and reliable testing. Generally, COVID-19 testing falls into two categories: diagnostic testing and serology testing. Diagnostic testing checks for the presence of the virus, while serology testing looks for the presence of antibodies that are formed by the body in response to the virus. Serology testing is less certain than diagnostic testing because the body generally takes one to three weeks to develop the antibodies after contracting COVID-19. For instance, a person could undergo a serology test and be found to have no antibodies, even though they could, in fact, be infected with COVID-19. Accordingly, the FDA has stated that serology testing should not be used to diagnose active COVID-19 infections.
Diagnostic testing is generally considered more accurate than serology testing for detecting the presence of the virus. Accordingly, the FDA has issued "Emergency Use Authorizations" (EUA) to certain diagnostic tests of COVID-19. An EUA essentially gives the FDA the authority to allow unapproved products to be used in emergency situations. Laboratories must submit an application with information regarding the effectiveness of their product in order to obtain EUA certification from the FDA. You can view a list of the COVID-19 tests that have received EUA certification on the FDA's website.
Employers will welcome the EEOC's guidance confirming they can require COVID-19 testing of their employees without running afoul of the ADA. At the same time, employers considering COVID-19 testing of employees should ensure that they follow the EEOC's guidance and choose reliable and accurate testing. Although the EEOC guidance does not explicitly state that an "accurate and reliable" test must have EUA certification, employers should still consider using diagnostic tests that have received EUA certification, as these should satisfy the EEOC's guidance.
Topics
Related Capabilities
Featured Insights

In The News
Oct 23, 2026
Michael Dowell Discusses Potential Impact of Proposition 44 on California Community Clinics

In The News
Oct 21, 2026
Scott Seaman Says Walmart Ruling is an "Aberration" in the Opioid Insurance Battle

Event
October 21 – 23, 2026
D.L. Morriss Presents on International Banking Litigation and AI Regulation

Press Release
Oct 20, 2026
Seasoned Litigator Joins Hinshaw's Aviation and Aerospace Team in Chicago

Consumer Crossroads: Where Financial Services and Litigation Intersect
Oct 19, 2026
Refile, Repeat: Ohio’s Savings Statute Allows for Unlimited Bites of a Time-Barred Claim

Consumer Crossroads: Where Financial Services and Litigation Intersect
Oct 16, 2026
Key Takeaways from the 2026 ACVL Conference for the Auto Finance Industry

Press Release
Oct 16, 2026
Nia Binns Re-Appointed Health and Wellness Committee Co-Chair of the BWLA

In The News
Oct 16, 2026
Jennifer Driscoll Explains How Bond Request Spurred AG Settlement in Paramount Merger

Consumer Crossroads: Where Financial Services and Litigation Intersect
Oct 15, 2026
OCC Releases Debanking Report on Largest Banks; CFPB Announces Follow-On Initiative



